Compare Cardinal Health Inc (CAH) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Vistra Corp — how do they compare? Cardinal Health Inc trades at $236.2 (market cap $55.88B), while Vistra Corp trades at $146.68 (market cap $48.64B). The key difference: Cardinal Health Inc and Vistra Corp are close in size by market cap, and Cardinal Health Inc pays the higher dividend (0.86%). Which is the better fit depends on your goals.
| CAH | VST | |
|---|---|---|
Market Cap | $55.88B | $48.64B |
Sector | Health | Technology |
52-Week High | $240.26 | $217.92 |
52-Week Low | $146.04 | $134.71 |
Enterprise Value | $59.91B | $70.58B |
Dividend Yield | 0.86% | 0.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $237.18, up 0.33% on the day, near its 52-week high. The stock shows bullish technical signals with consistent earnings beats, including Q2 2026 EPS of $2.91 versus $2.42 expected. Revenue reached $222.58 billion in 2025, with net income margin improving to 0.67%. Positive sentiment is driven by strong Q4 2026 results and optimistic fiscal 2027 guidance highlighted by Reuters on August 11, 2026.
Outlook remains favorable with analyst consensus price target of $266.43 implying 12% upside. Key opportunities include pharmaceutical segment strength and dividend payments, while risks involve high debt levels and thin profit margins. The bullish analyst stance (54.55% buy ratings) supports growth potential, but investors should monitor cash flow volatility and competitive pressures.
VST trades at $147.54, up 3.27% today, with strong analyst support (90.9% buy ratings) and a $239.75 consensus price target suggesting 62% upside. Recent Q2 2026 earnings showed mixed results with an EPS miss but 30% EBITDA growth to $1.77 billion, driven by data center demand. Technical indicators are bearish with support at $141, while fundamentals show robust profitability (11.55% net margin) offset by high valuation multiples (P/E 24.44).
The outlook remains positive given Vistra's positioning in the AI-powered data center boom, though risks include ERCOT pricing volatility and hedging losses. With institutional ownership stable and dividend payments consistent, the stock offers growth exposure to electricity demand trends, but investors should monitor execution on 2026 guidance and competitive pressures in the utility sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
